Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesSite-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients
BMC Cancer, 10/09/09
Lin Y et al. – Based on the site–specific spread pattern in different subgroups, the triple negative category of breast cancers in the Chinese population exhibits a different pattern of relapse, which indicates that different organotropism may be due to the different intrinsic subtypes. A better knowledge of the triple negative category is warranted for efficacious systemic regimens to decrease and/or delay the relapse hazard.
Related Articles
The association of metabolic syndrome with triple-negative breast cancer
Breast Cancer Research and Treatment, 10/28/09
Relevance Score: 83%
Expression of androgen receptors in primary breast cancer
Annals of Oncology, 11/16/09
Relevance Score: 80%
High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller
Journal of Clinical Oncology, 11/06/09
Relevance Score: 68%
Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer
Modern Pathology, 10/28/09
Relevance Score: 68%
Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status
Anti-Cancer Drugs, 10/16/09
Relevance Score: 68%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 11/30/09
Efficacy of oral tegafur-uracil (UFT) as adjuvant therapy as compared with classical cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in early breast cancer: A pooled analysis of two randomized controlled trials (N·SAS-BC 01 trial and CUBC trial)
Breast Cancer Research and Treatment, 11/30/09
Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: A meta-analysis involving 46,281 subjects
Breast Cancer Research and Treatment, 11/30/09
Sponsor
Article Search
Sponsor
Sponsor